Cargando…
Modified mRNA Formulation and Stability for Cardiac and Skeletal Muscle Delivery
Directly injecting naked or lipid nanoparticle (LNP)-encapsulated modified mRNA (modRNA) allows rapid and efficient protein expression. This non-viral technology has been used successfully in modRNA vaccines against SARS-CoV-2. The main challenges in using modRNA vaccines were the initial requiremen...
Autores principales: | Żak, Magdalena M., Kaur, Keerat, Yoo, Jimeen, Kurian, Ann Anu, Adjmi, Matthew, Mainkar, Gayatri, Yoon, Seonghun, Zangi, Lior |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10535735/ https://www.ncbi.nlm.nih.gov/pubmed/37765147 http://dx.doi.org/10.3390/pharmaceutics15092176 |
Ejemplares similares
-
Modified mRNA as a Therapeutic Tool for the Heart
por: Kaur, Keerat, et al.
Publicado: (2020) -
Therapeutic Delivery of Pip4k2c‐Modified mRNA Attenuates Cardiac Hypertrophy and Fibrosis in the Failing Heart
por: Magadum, Ajit, et al.
Publicado: (2021) -
mRNA-Based Protein Replacement Therapy for the Heart
por: Magadum, Ajit, et al.
Publicado: (2019) -
Optimization of 5′ Untranslated Region of Modified mRNA for Use in Cardiac or Hepatic Ischemic Injury
por: Sultana, Nishat, et al.
Publicado: (2020) -
Lipid Nanoparticles for Organ-Specific mRNA Therapeutic Delivery
por: Żak, Magdalena M., et al.
Publicado: (2021)